Journal of Leukocyte Biology BioLegend: Treg, Th17, Stem Cell
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Originally published online as doi:10.1189/jlb.0702351 on May 22, 2003

Published online before print May 22, 2003
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jlb.0702351v1
74/1/60    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bolton, S. J.
Right arrow Articles by Wardlaw, A. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bolton, S. J.
Right arrow Articles by Wardlaw, A. J.
(Journal of Leukocyte Biology. 2003;74:60-68.)
© 2003 by Society for Leukocyte Biology

Expression of and functional responses to protease-activated receptors on human eosinophils

Sarah J. Bolton*, Clare A. McNulty*, Rebecca J. Thomas*, Colin R. A. Hewitt{dagger} and Andrew J. Wardlaw*

Institute for Lung Health,
* Division of Respiratory Medicine, Leicester Warwick Medical School, and
{dagger} Department of Microbiology and Immunology, School of Biological Sciences, Maurice Shock Medical Science Building, Leicester University, United Kingdom

Correspondence: Sarah Bolton, Division of Respiratory Medicine, Leicester University, Clinical Sciences, Glenfield Hospital, Groby Road, Leicester LE3 9QP, UK. E-mail: sjb73{at}leicester.ac.uk

Eosinophil recruitment to airway tissue is a key feature of asthma, and release of a wide variety of toxic mediators from eosinophils leads to the tissue damage that is a hallmark of asthma pathology. Factors that control the release of these toxic mediators are targets for potential therapeutic intervention. Protease-activated receptors (PARs) are a novel class of receptors that are activated by cleavage of the N terminus of the receptor by proteases such as thrombin or trypsin-like enzymes. To date, PAR1–4 have been identified, and there are several studies that have demonstrated the expression of PARs in airway tissue, particularly the respiratory epithelium. We have investigated whether eosinophils express PARs and if activation of these receptors will then trigger a functional response. Using a combination of reverse transcriptase-polymerase chain reaction, Western blotting, and flow cytometry analysis, we have demonstrated that eosinophils express PAR1 and PAR2. FACS analysis showed that PAR1 could be clearly detected on the surface of the cells, whereas PAR2 appeared to be primarily intracellular. Trypsin and the PAR2 agonist peptide were seen in trigger shape change, release of cysteinyl leukotrienes, and most obviously, generation of reactive oxygen species. In contrast, thrombin had no effect on eosinophil function. The PAR1 agonist peptide did have a minor effect on eosinophil function, but this was most likely down to its ability to activate PAR1 and PAR2. These results demonstrate that PAR2 is the major PAR receptor that is capable of modulating eosinophil function.

Key Words: trypsin • thrombin • activation




This article has been cited by other articles:


Home page
 GutHome page
E Hyun, P Andrade-Gordon, M Steinhoff, and N Vergnolle
Protease-activated receptor-2 activation: a major actor in intestinal inflammation
Gut, September 1, 2008; 57(9): 1222 - 1229.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
V. Shpacovitch, M. Feld, M. D. Hollenberg, T. A. Luger, and M. Steinhoff
Role of protease-activated receptors in inflammatory responses, innate and adaptive immunity
J. Leukoc. Biol., June 1, 2008; 83(6): 1309 - 1322.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. Zoudilova, P. Kumar, L. Ge, P. Wang, G. M. Bokoch, and K. A. DeFea
beta-Arrestin-dependent Regulation of the Cofilin Pathway Downstream of Protease-activated Receptor-2
J. Biol. Chem., July 13, 2007; 282(28): 20634 - 20646.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
R. Ramachandran, L. R. Sadofsky, Y. Xiao, A. Botham, M. Cowen, A. H. Morice, and S. J Compton
Inflammatory mediators modulate thrombin and cathepsin-G signaling in human bronchial fibroblasts by inducing expression of proteinase-activated receptor-4
Am J Physiol Lung Cell Mol Physiol, March 1, 2007; 292(3): L788 - L798.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
N. Tyagi, K. C. Sedoris, M. Steed, A. V. Ovechkin, K. S. Moshal, and S. C. Tyagi
Mechanisms of homocysteine-induced oxidative stress
Am J Physiol Heart Circ Physiol, December 1, 2005; 289(6): H2649 - H2656.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
U. Johansson, C. Lawson, M. Dabare, D. Syndercombe-Court, A. C. Newland, G. L. Howells, and M. G. Macey
Human peripheral blood monocytes express protease receptor-2 and respond to receptor activation by production of IL-6, IL-8, and IL-1{beta}
J. Leukoc. Biol., October 1, 2005; 78(4): 967 - 975.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
J. M. Swartz, J. Bystrom, K. D. Dyer, T. Nitto, T. A. Wynn, and H. F. Rosenberg
Plasminogen activator inhibitor-2 (PAI-2) in eosinophilic leukocytes
J. Leukoc. Biol., October 1, 2004; 76(4): 812 - 819.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the Society for Leukocyte Biology.